文献速递腹部泌尿生殖MR

模拟「短」钆塞酸二钠增强MRI方案检测结直肠癌肝转移的诊断效能与常规方案相似

The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
PubMed 文献 · Eur Radiol · 2020-10-06

回顾性纳入2008至2017年67例初诊结直肠癌并接受钆塞酸二钠增强MRI的患者,两位阅片者分别按标准「长」方案(全部序列)与模拟「短」方案(仅T2加权、扩散加权和肝胆期)独立判读。短方案与长方案的转移瘤检出率和正确分类率均无显著差异,作者认为短方案可缩短检查时间、便于评估结直肠癌肝转移。

要点

  • 仅用T2加权、扩散加权和肝胆期图像的模拟短方案,转移瘤检出率与包含动态期的标准长方案相似。
  • 短方案与长方案对转移瘤与良性病变的正确分类率无显著差异,按5分法评分≥3分判为转移瘤。
  • 作者认为短方案可缩短MR检查时间,便于评估结直肠癌肝转移患者。

核心结论

  • 包含T2加权、扩散加权和肝胆期的模拟短钆塞酸二钠增强MR方案,其诊断效能与包含动态期图像的标准长方案似乎相似。
  • 由于该方案缩短MR检查时间,可能便于评估结直肠癌肝转移患者。

研究设计与样本

  • 2008至2017年纳入67例初诊结直肠癌并接受钆塞酸二钠增强MRI的患者,其中男性44例(66%),平均年龄65±11岁。
  • 两位阅片者在不知临床数据的情况下独立判读,分两次阅片:标准「长」方案为全部采集序列,模拟「短」方案仅含T2加权、扩散加权和肝胆期图像。
  • 阅片者用5分法(1分肯定良性至5分肯定恶性)对检出病灶定性,评分≥3分判为结直肠癌肝转移。
  • 参考标准为组织病理学或12个月影像随访,比较采用卡方检验、Student t检验和McNemar检验。

诊断标准与关键数值

  • 共分析486个病灶,其中331个为转移瘤(68%)。
  • 短方案转移瘤检出率86.1%(95%CI 82-89.4)至86.7%(95%CI 82.6-90),长方案85.8%(95%CI 81.6-89.2)至87%(95%CI 82.9-90.2),两者比较p>0.99。
  • 检出病灶中,短方案正确分类率92.1%(95%CI 89.1-94.4)至94.8%(95%CI 92.2-96.6),长方案84.6%(95%CI 80.8-87.7)至88.8%(95%CI 85.4-91.5),分别p=0.13和p=0.10。
  • 以评分≥4分判为结直肠癌肝转移时,结果保持不变。

临床应用与阅片要点

  • 作者认为,含T2加权、扩散加权和肝胆期的短MR方案与含动态期的标准长方案诊断效能似乎相似。
  • 作者认为,该短方案可缩短MR检查时间,可能便于评估结直肠癌肝转移患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the performance of standard and simulated short gadoxetic acid-enhanced MRI protocols for the detection of colorectal liver metastases (CRLM).

METHODS: From 2008 to 2017, 67 patients (44 men (66%); mean age 65 ± 11 years old) who underwent gadoxetic acid-enhanced MRI during the initial work-up for colorectal cancer were included. Exams were independently reviewed by two readers blinded to clinical data in two reading sessions: (1) all acquired sequences (standard "long" protocol) and (2) only T2-weighted, diffusion-weighted, and hepatobiliary phase images (simulated "short" protocol). Readers characterized detected lesions using a 5-point scale (1-certainly benign to 5-certainly malignant). A lesion was considered a CRLM when the score was ≥ 3. The reference standard was histopathology or 12-month imaging follow-up. Chi-square, Student's t, and McNemar tests were used for comparisons.

RESULTS: A total of 486 lesions including 331 metastases (68%) were analyzed. The metastasis detection rate was 86.1% (95% CI 82-89.4)-86.7% (82.6-90) and 85.8% (81.6-89.2)-87% (82.9-90.2) with the short and long protocols, respectively (p > 0.99). Among detected lesions, 92.1% (89.1-94.4)-94.8% (92.2-96.6) and 84.6% (80.8-87.7)-88.8% (85.4-91.5) were correctly classified with the short and long protocols, respectively (p = 0.13 and p = 0.10). The results remained unchanged when lesions scored ≥ 4 were considered as CRLM.

CONCLUSION: The diagnostic performance of a simulated short gadoxetic enhanced-MR protocol including T2-weighted, diffusion-weighted, and hepatobiliary phase appears similar to that of a standard long protocol including dynamic phase images. Since this protocol shortens the duration of MR examination, it could facilitate the evaluation of patients with colorectal liver metastases.

KEY POINTS: • The detection rate of colorectal metastases with a simulated, short, MRI protocol was similar to that of a standard protocol. • The performance of both protocols for the differentiation of metastases and benign lesions appears to be similar. • A short MR imaging protocol could facilitate the evaluation of patients with colorectal liver metastases.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ghorra C, Pommier R, Piveteau A, et al. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases. Eur Radiol. 2020. PMID: 33025173. doi:10.1007/s00330-020-07344-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。